课题基金 / 基金详情

CHEMICAL GENETIC IDENTIFICATION OF DIRECT KINASE SUBSTRATES

CHEMICAL GENETIC IDENTIFICATION OF DIRECT KINASE SUBSTRATES
直接激酶底物的化学遗传学鉴定
批准号:
8363761
负责人:
KEVAN M. SHOKAT
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-05-31

项目摘要

项目成果

KEVAN M. SHOKAT的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Protein phosphorylation is a major mechanism of post-translational protein modification used to control cellular signalling. A challenge in phosphoproteomics is to identify the direct substrates of each protein kinase. We have developed a chemical strategy for delivery of a bio-orthogonal affinity tag to the substrates of an individual protein kinase. The kinase of interest is engineered to transfer a phosphorothioate moiety to phosphoacceptor hydroxyl groups on direct substrates. In a second non-enzymatic step, the introduced phosphorothioate is alkylated with p-nitrobenzylmesylate (PNBM). Antibodies directed against the modified phosphorothioate epitope recognize these labelled substrates, but not alkylation products of other cellular nucleophiles. Immunoaffinity chromatography allows the purification of these substrates, and mass spectrometry provides an attractive method for their rapid identification.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Viral RNA Using a Sequence Programmable Small Molecule-Oligonucleotide Conjugate
Tissue-specific pharmacology to enhance healthspan
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis
Inhibitors of the G protein GNAS which drives pancreatic tumorigenesis
海外基金